Canada Markets open in 26 mins

Laboratory Corporation of America Holdings (LAB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
236.700.00 (0.00%)
As of 8:02AM CEST. Market open.

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127

IndustryDiagnostics & Research
Full Time Employees70,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Adam H. SchechterPres, CEO & Chairman4.87MN/A1965
Mr. Glenn A. EisenbergCFO & Exec. VP1.98MN/A1961
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPHExec. VP, Pres of Diagnostics & Chief Medical Officer1.37MN/A1974
Mr. Mark S. SchroederExec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain1.4MN/A1961
Dr. Paul R. Kirchgraber M.D.Exec. VP & CEO of Covance Drug Devel.1.4MN/A1962
Dr. Michelle AbelsonLaboratory Director of OperationsN/AN/AN/A
Mr. Peter J. WilkinsonSr. VP & Chief Accounting OfficerN/AN/A1971
Mr. Lance V. BerberianExec. VP and Chief Information & Technology OfficerN/AN/A1963
Dr. Marcia T. EisenbergChief Scientific Officer & Sr. VPN/AN/AN/A
Chas CookVP of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Corporate Governance

Laboratory Corporation of America Holdings’s ISS Governance QualityScore as of June 1, 2021 is 1. The pillar scores are Audit: 9; Board: 7; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.